Fintel reports that on January 23, 2025, Piper Sandler initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a ...

Travelers Companies Inc. (NYSE:TRV), a $54.7 billion insurance giant trading at 11.5x earnings, received an upgrade in its ...

Piper Sandler analyst Michael Lavery maintained a Buy rating on PepsiCo (PEP – Research Report) today and set a price target of $171.00. The ...

Piper Sandler analyst Alexander Potter upgraded Aptiv (APTV) to Neutral from Underweight with a price target of $65, up from $53, after the ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

Elon Musk's Tesla could deliver a choppy H1 given tailwinds from Donald Trump's EV policies, uncertainties in deliveries, and gross margin.

On Wednesday, Baker Hughes Co (BKR) stock saw a decline, ending the day at $45.81 which represents a decrease of $-1.23 or -2.61% from the prior close of $47.04. The stock opened at $47.04 and touched ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Tesla (TSLA) slips as President Trump considers eliminating EV tax credits and subsidies, while Piper Sandler analysts raise ...

On Friday, Piper Sandler reaffirmed its Overweight rating on Boot Barn (NYSE:NYSE:BOOT) shares, with a steady price target of $179.00. According to InvestingPro data, analyst targets range from $ ...

On Friday, Piper Sandler adjusted its outlook on Keros Therapeutics (NASDAQ:KROS), significantly reducing the price target from $40.00 to $15.00, while still maintaining an Overweight rating on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...